You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026
Filter Results
Select search scope: search across all journals or within the current journal
Search this journal
Enter search terms…
/
You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026
Select search scope: search across all journals or within the current journal
This international peer-reviewed open access journal is dedicated to revolutionizing diabetes and obesity management using advanced technologies, innovative therapeutic strategies, and the integration of artificial intelligence (AI). The journal's mission is to equip healthcare professionals with cutting-edge insights into emerging devices, advanced pharmacological treatments, innovative drug delivery systems, and state-of-the-art software solutions, including AI-driven tools related to diabetes and obesity. Each volume of this OA journal explores groundbreaking research and its practical applications in clinical settings, aiming to bridge the gap between scientific discovery and clinical practice. By promoting a multidisciplinary approach and leveraging AI for improved diagnostic accuracy, personalized treatment plans, and enhanced patient monitoring, we aim to redefine excellence in diabetes and obesity care, ultimately improving patient outcomes and quality of life.
The article processing charge (APC) for this journal is $2250 USD.